Eliquis and Malignant neoplasm progression - a phase IV clinical study of FDA data
Summary:
Malignant neoplasm progression is reported as a side effect among people who take Eliquis (apixaban), especially for people who are female, 60+ old, have been taking the drug for 1 - 6 months also take Keytruda, and have Endometrial cancer.
The phase IV clinical study analyzes which people have Malignant neoplasm progression when taking Eliquis. It is created by eHealthMe based on reports of 189,425 people who have side effects when taking Eliquis from the FDA, and is updated regularly.
What is Eliquis?
Eliquis has active ingredients of apixaban. It is often used in atrial fibrillation/flutter. eHealthMe is studying from 191,859 Eliquis users. Check the latest studies of Eliquis.
What is Malignant neoplasm progression?
Malignant neoplasm progression (cancer tumour came back) is found to be associated with 1,514 drugs and 1,634 conditions by eHealthMe. Check the latest studies of Malignant neoplasm progression.
189,425 people reported to have side effects when taking Eliquis.
Among them, 716 people (0.38%) have Malignant neoplasm progression.
Among these 716 people:
How long have people been on Eliquis when they have Malignant neoplasm progression? *
What is the gender of people who have Malignant neoplasm progression when taking Eliquis? *
What is the age of people who have Malignant neoplasm progression when taking Eliquis? *
What are other drugs people take besides Eliquis? *
What are other side effects people have besides Malignant neoplasm progression? *
What are the existing conditions these people have? *
* Approximation only. Some reports may have incomplete information.
Do you take Eliquis and have Malignant neoplasm progression?
- Check whether Malignant neoplasm progression is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Eliquis:
- Eliquis (191,859 reports)
Malignant neoplasm progression treatments and more:
- Malignant neoplasm progression (107,528 reports)
How severe was Malignant neoplasm progression and when was it recovered:
Expand to all the drugs that have ingredients of apixaban:
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Eliquis:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Malignant neoplasm progression:
- Malignant neoplasm progression (1,514 drugs)
Browse all the conditions that are associated with Malignant neoplasm progression:
- Malignant neoplasm progression (1,634 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on apixaban (the active ingredients of Eliquis) and Eliquis (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Nystatin and Argatroban - 5 seconds ago
- Could Flovent cause Graft Versus Host Disease? - 9 seconds ago
- Could Oxaliplatin cause Hip Fracture? - 12 seconds ago
- Could Advil Liqui-Gels cause Anaemia Of Malignant Disease? - 24 seconds ago
- Could Metoprolol Succinate cause Complications Of Transplanted Kidney? - 43 seconds ago
- Drug interactions of Hetlioz and Proair Hfa - 44 seconds ago
- Could Nafcillin Sodium cause Haemoglobin Decreased? - 45 seconds ago
- How effective is Klonopin for Bipolar Ii Disorder? - 46 seconds ago
- Could Sandostatin cause Light Chain Analysis Increased? - 49 seconds ago
- Mental Disorder and Consciousness - Decreased - a minute ago